SG10201706968UA - Biodegradable and clinically-compatible nanoparticles as drug delivery carriers - Google Patents
Biodegradable and clinically-compatible nanoparticles as drug delivery carriersInfo
- Publication number
- SG10201706968UA SG10201706968UA SG10201706968UA SG10201706968UA SG10201706968UA SG 10201706968U A SG10201706968U A SG 10201706968UA SG 10201706968U A SG10201706968U A SG 10201706968UA SG 10201706968U A SG10201706968U A SG 10201706968UA SG 10201706968U A SG10201706968U A SG 10201706968UA
- Authority
- SG
- Singapore
- Prior art keywords
- biodegradable
- clinically
- drug delivery
- delivery carriers
- compatible nanoparticles
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6923—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5115—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5169—Proteins, e.g. albumin, gelatin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/30—Special therapeutic applications
- C12N2320/32—Special delivery means, e.g. tissue-specific
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Inorganic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Ceramic Engineering (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361761012P | 2013-02-05 | 2013-02-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201706968UA true SG10201706968UA (en) | 2017-09-28 |
Family
ID=51300093
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201706968UA SG10201706968UA (en) | 2013-02-05 | 2014-02-05 | Biodegradable and clinically-compatible nanoparticles as drug delivery carriers |
SG11201506116XA SG11201506116XA (en) | 2013-02-05 | 2014-02-05 | Biodegradable and clinically-compatible nanop articles as drug delivery carriers |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201506116XA SG11201506116XA (en) | 2013-02-05 | 2014-02-05 | Biodegradable and clinically-compatible nanop articles as drug delivery carriers |
Country Status (14)
Country | Link |
---|---|
US (2) | US11001840B2 (ru) |
EP (2) | EP2953646B1 (ru) |
JP (1) | JP6507102B2 (ru) |
KR (1) | KR20150132131A (ru) |
AU (2) | AU2014215421A1 (ru) |
CA (1) | CA2899155A1 (ru) |
ES (1) | ES2873600T3 (ru) |
HK (1) | HK1217906A1 (ru) |
IL (1) | IL240148A0 (ru) |
MX (1) | MX2015010083A (ru) |
RU (1) | RU2015137815A (ru) |
SG (2) | SG10201706968UA (ru) |
WO (1) | WO2014123935A1 (ru) |
ZA (1) | ZA201506530B (ru) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20150132131A (ko) | 2013-02-05 | 2015-11-25 | 1글로브 헬스 인스티튜트 엘엘씨 | 약물 전달 담체로서 생체분해가능하고 임상적으로 상용가능한 나노입자 |
JP6697384B2 (ja) | 2013-07-25 | 2020-05-20 | イグジキュア, インコーポレーテッドExicure, Inc. | 予防的および治療的使用のための免疫刺激剤としての球状の核酸ベース構築物 |
ES2725948T3 (es) | 2014-06-04 | 2019-09-30 | Exicure Inc | Suministro multivalente de inmunomoduladores mediante ácidos nucleicos esféricos liposomales para aplicaciones profilácticas o terapéuticas |
US11213593B2 (en) | 2014-11-21 | 2022-01-04 | Northwestern University | Sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates |
EP3247796A4 (en) * | 2015-01-14 | 2018-07-11 | Exicure, Inc. | Nucleic acid nanostructures with core motifs |
CA3023451A1 (en) | 2016-05-06 | 2017-11-09 | Exicure, Inc. | Liposomal spherical nucleic acid (sna) constructs presenting antisense oligonucleotides (aso) for specific knockdown of interleukin 17 receptor mrna |
WO2018039629A2 (en) | 2016-08-25 | 2018-03-01 | Northwestern University | Micellar spherical nucleic acids from thermoresponsive, traceless templates |
WO2018098352A2 (en) | 2016-11-22 | 2018-05-31 | Jun Oishi | Targeting kras induced immune checkpoint expression |
US10800817B2 (en) * | 2016-12-19 | 2020-10-13 | Morehouse School Of Medicine | Compositions and methods for treating diseases by inhibiting exosome release |
EP3568122B1 (en) * | 2017-01-10 | 2023-10-04 | Dukebox SP. Z O.O. | A method of manufacturing a suspension of nanoparticles of potassium salt or magnesium salt |
US11696954B2 (en) | 2017-04-28 | 2023-07-11 | Exicure Operating Company | Synthesis of spherical nucleic acids using lipophilic moieties |
WO2018209270A1 (en) | 2017-05-11 | 2018-11-15 | Northwestern University | Adoptive cell therapy using spherical nucleic acids (snas) |
KR102120482B1 (ko) * | 2018-10-05 | 2020-06-08 | 씨제이제일제당 (주) | 생분해성 고분자 나노입자를 포함하는 메모리 소자 및 이의 제조방법 |
US20230149561A1 (en) * | 2019-07-12 | 2023-05-18 | The Board Of Trustees Of The Leland Stanford Junior University | Functionalized Nanoparticles and Their Use in Treating Bacterial Infections |
WO2021067952A1 (en) * | 2019-10-04 | 2021-04-08 | The University Of Chicago | Targeted nanomedicine for treating vascular disorders |
EP4100021A4 (en) * | 2020-02-03 | 2023-11-15 | Rutgers, the State University of New Jersey | MICRORNA-7 COMPOSITIONS FOR PROMOTING FUNCTIONAL RECOVERY FOLLOWING SPINAL TRAUMA AND METHODS OF USE THEREOF |
US11998615B2 (en) | 2021-04-14 | 2024-06-04 | The Board Of Trustees Of The Leland Stanford Junior University | Functionalized nanoparticles and their use in treating bacterial infections |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5219577A (en) | 1990-06-22 | 1993-06-15 | The Regents Of The University Of California | Biologically active composition having a nanocrystalline core |
TW406020B (en) * | 1993-09-29 | 2000-09-21 | Bristol Myers Squibb Co | Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent |
US5879715A (en) * | 1997-09-02 | 1999-03-09 | Ceramem Corporation | Process and system for production of inorganic nanoparticles |
DE19856432A1 (de) * | 1998-12-08 | 2000-06-15 | Basf Ag | Nanopartikuläre Kern-Schale Systeme sowie deren Verwendung in pharmazeutischen und kosmetischen Zubereitungen |
DE19912502A1 (de) | 1999-03-19 | 2000-09-21 | Inst Neue Mat Gemein Gmbh | Nanoskalige Teilchen, Komplexe mit Polynukleotiden und deren Verwendung |
CA2426244A1 (en) | 2000-10-25 | 2002-05-02 | The University Of British Columbia | Lipid formulations for target delivery |
IN192520B (ru) * | 2001-08-01 | 2004-04-24 | Univ Delhi | |
CA2532228C (en) | 2003-07-16 | 2017-02-14 | Protiva Biotherapeutics, Inc. | Lipid encapsulated interfering rna |
KR20070002014A (ko) | 2004-02-13 | 2007-01-04 | 노드 파마수티칼스, 인코포레이티드 | 치료용 인산칼슘 입자, 그 제조 방법 및 그 이용 방법 |
US7611690B2 (en) | 2005-01-04 | 2009-11-03 | Gp Medical, Inc. | Nanoparticles for protein drug delivery |
JPWO2007000939A1 (ja) | 2005-06-28 | 2009-01-22 | 学校法人 聖マリアンナ医科大学 | 局所炎症治療用薬剤 |
CN100435784C (zh) * | 2005-07-25 | 2008-11-26 | 管晓虹 | 含有和包封中药成分的无机盐纳米粒子的制备方法 |
US20080248108A1 (en) * | 2006-10-06 | 2008-10-09 | Jain Krotz | Multilayered polyelectrolyte-based capsules for cell encapsulation and delivery of therapeutic compositions |
JP5744513B2 (ja) | 2007-04-17 | 2015-07-08 | バクスター・インターナショナル・インコーポレイテッドBaxter International Incorp0Rated | 肺送達のための核酸微小粒子 |
JP2010533730A (ja) * | 2007-07-16 | 2010-10-28 | ノースイースタン・ユニバーシティ | 安定した治療用ナノ粒子 |
JP2010537640A (ja) * | 2007-08-27 | 2010-12-09 | ボストン バイオメディカル, インコーポレイテッド | マイクロrna模倣剤または阻害剤としての非対称性rna二重鎖の組成物 |
US20100204303A1 (en) | 2007-09-25 | 2010-08-12 | Idexx Laboratories, Inc. | Pharmaceutical Compositions for Administering Oligonucleotides |
EP2241314B1 (en) | 2007-12-14 | 2013-04-17 | Ezaki Glico Co., Ltd. | Alpha-lipoic acid nanoparticle and method for producing the same |
US20110038941A1 (en) | 2007-12-27 | 2011-02-17 | The Ohio State University Research Foundation | Lipid Nanoparticle Compositions and Methods of Making and Using the Same |
MX2010012236A (es) | 2008-05-13 | 2011-06-20 | Univ Washington | Portador polimerico. |
EP2421880A4 (en) | 2008-11-26 | 2012-11-28 | Univ Kansas | COMPOSITIONS AND METHODS FOR NUCLEIC ACID DELIVERY |
EP2198885B1 (en) * | 2008-12-19 | 2012-02-08 | Biolitec AG | Calcium phosphate nanoparticles as dye carrier for photodynamic therapy |
WO2011017297A2 (en) * | 2009-08-03 | 2011-02-10 | The University Of North Carolina At Chapel Hill | Biodegradable delivery system complexes for the delivery of bioactive compounds |
WO2011030946A1 (ko) * | 2009-09-14 | 2011-03-17 | 주식회사 나노하이브리드 | 표적지향성 sirna-층상형 무기 수산화물 나노혼성체, 그 제조방법, 및 나노혼성체를 함유하는 종양 치료용 약학 조성물 |
JP5491119B2 (ja) * | 2009-10-02 | 2014-05-14 | 日東電工株式会社 | 薬物含有微粒子を含む医薬組成物およびその製造方法 |
US9375400B2 (en) * | 2011-09-14 | 2016-06-28 | University Of South Florida | Manganese ion coated nanoparticles for delivery of compositions into the central nervous system by nasal insufflation |
TR201904389T4 (tr) | 2011-11-04 | 2019-04-22 | Nitto Denko Corp | Lipit nükleik asit partiküllerinin steril bir şekilde üretilmesine yönelik yöntem. |
US20130243699A1 (en) | 2011-12-07 | 2013-09-19 | Regents Of The University Of Minnesota | Biodegradable Magnetic Nanoparticles and Related Methods |
ITRM20120480A1 (it) | 2012-10-09 | 2014-04-10 | Uni Degli Studi Camerino | Nanoparticelle lipidiche multicomponenti e procedimenti per la loro preparazione. |
KR20150132131A (ko) | 2013-02-05 | 2015-11-25 | 1글로브 헬스 인스티튜트 엘엘씨 | 약물 전달 담체로서 생체분해가능하고 임상적으로 상용가능한 나노입자 |
-
2014
- 2014-02-05 KR KR1020157024176A patent/KR20150132131A/ko not_active Application Discontinuation
- 2014-02-05 SG SG10201706968UA patent/SG10201706968UA/en unknown
- 2014-02-05 AU AU2014215421A patent/AU2014215421A1/en not_active Abandoned
- 2014-02-05 EP EP14748796.1A patent/EP2953646B1/en active Active
- 2014-02-05 RU RU2015137815A patent/RU2015137815A/ru not_active Application Discontinuation
- 2014-02-05 MX MX2015010083A patent/MX2015010083A/es unknown
- 2014-02-05 JP JP2015556243A patent/JP6507102B2/ja active Active
- 2014-02-05 SG SG11201506116XA patent/SG11201506116XA/en unknown
- 2014-02-05 US US14/765,763 patent/US11001840B2/en active Active
- 2014-02-05 WO PCT/US2014/014751 patent/WO2014123935A1/en active Application Filing
- 2014-02-05 ES ES14748796T patent/ES2873600T3/es active Active
- 2014-02-05 CA CA2899155A patent/CA2899155A1/en not_active Abandoned
- 2014-02-05 EP EP20204049.9A patent/EP3845248A1/en active Pending
-
2015
- 2015-07-26 IL IL240148A patent/IL240148A0/en unknown
- 2015-09-04 ZA ZA2015/06530A patent/ZA201506530B/en unknown
-
2016
- 2016-05-24 HK HK16105903.7A patent/HK1217906A1/zh unknown
-
2018
- 2018-02-07 AU AU2018200903A patent/AU2018200903A1/en not_active Abandoned
-
2021
- 2021-04-06 US US17/223,647 patent/US20210230595A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20210230595A1 (en) | 2021-07-29 |
WO2014123935A9 (en) | 2014-10-23 |
ZA201506530B (en) | 2018-11-28 |
HK1217906A1 (zh) | 2017-01-27 |
EP3845248A1 (en) | 2021-07-07 |
WO2014123935A1 (en) | 2014-08-14 |
JP6507102B2 (ja) | 2019-04-24 |
JP2016513090A (ja) | 2016-05-12 |
AU2014215421A1 (en) | 2015-08-13 |
MX2015010083A (es) | 2016-04-26 |
IL240148A0 (en) | 2015-09-24 |
EP2953646A1 (en) | 2015-12-16 |
RU2015137815A (ru) | 2017-03-13 |
EP2953646B1 (en) | 2021-03-10 |
AU2018200903A1 (en) | 2018-02-22 |
SG11201506116XA (en) | 2015-09-29 |
EP2953646A4 (en) | 2017-02-15 |
US20160046936A1 (en) | 2016-02-18 |
US11001840B2 (en) | 2021-05-11 |
CA2899155A1 (en) | 2014-08-14 |
ES2873600T3 (es) | 2021-11-03 |
KR20150132131A (ko) | 2015-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201506530B (en) | Biodegradable and clinically-compatible nanoparticles as drug delivery carriers | |
HK1259482A1 (zh) | 具有受控的藥物輸送的植入物 | |
HK1218850A1 (zh) | 持續藥物遞送植入物 | |
EP2983659A4 (en) | DRUG DELIVERY POLYMER AND USES THEREOF | |
HK1211517A1 (en) | Drug delivery device | |
SG11201500937UA (en) | Extrusion methods and devices for drug delivery | |
HK1211520A1 (en) | Drug delivery device | |
ZA201505735B (en) | Cancer drug and uses | |
IL245544A0 (en) | drug delivery system | |
SG11201508647UA (en) | Drug delivery device | |
IL240849A0 (en) | Drug delivery devices and drug delivery method | |
EP2961469A4 (en) | DEVICE FOR DELIVERY OF MEDICAMENT | |
HK1211519A1 (en) | Drug delivery device | |
GB201313782D0 (en) | Drug delivery device | |
EP2825129A4 (en) | VASCULAR ENDOPROTHESIS AND DEVICE FOR IMPLEMENTING VASCULAR ENDOPROTHESIS | |
EP2950785A4 (en) | NANOPARTICLE-drug delivery systems | |
HK1216083A1 (zh) | 經動脈的藥物遞送 | |
EP4005604C0 (en) | ADMINISTRATION OF MEDICINES | |
GB201314312D0 (en) | Composition and delivery system | |
SG11201600371XA (en) | Drug delivery device | |
HK1219451A1 (zh) | 藥物輸送裝置 | |
HK1219450A1 (zh) | 藥物輸送裝置 | |
HK1219682A1 (zh) | 藥物輸送裝置 | |
HK1219685A1 (zh) | 藥物輸送裝置 | |
HK1219681A1 (zh) | 藥物輸送裝置 |